Protara Therapeutics, Inc. — Director's Dealing 2015

Jun 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2015-06-02

Reporting Person: O'Leary Brendan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-02	Stock Option (Right to Buy)	$17.59	A	6666	Acquired	2025-06-02	Common Stock, $0.001 par value (6666)	Direct

Footnotes

F1: The options were granted on June 2, 2015 and the shares underlying this option will vest 100% at the earlier of (i) June 2, 2016 and (ii) the Issuer's next annual meeting of stockholders.